Literature DB >> 6190906

The cell surface phenotype of a naturally occurring human suppressor T-cell of restricted specificity: definition by monoclonal antibodies.

V Brankovan, M A Bean, P J Martin, J A Hansen, K Sadamoto, Y Takahashi, M Akiyama.   

Abstract

A series of murine monoclonal antibodies was used to characterize the surface phenotype of a naturally occurring E+ B14-specific suppressor cell present in the blood of a patient with recurrent superficial bladder carcinomas. This suppressor T cell is different from the few naturally occurring suppressors of MLC reported by others in that its function does not require HLA-D compatibility with the cells being suppressed. This patient's T cells had decreased proportions of T3+, 10.2+, 9.3+, and T4+ cells, a normal proportion of T8+ cells, and a markedly increased proportion of Ia-positive cells. The MLC-suppressor assay was used to test the functional activity of cell populations selectively depleted by treatment with monoclonal antibodies and C or enriched by panning. The B14-specific suppressor T cells in this patient expressed T cell markers recognized by monoclonal antibodies 9.6, T3, and the T cell subset marker identified by OKT8 (T8+) but not the subset marker identified by OKT4 (T4-). Ia antigens were present on a substantial portion of these suppressor T cells. Thus, this unique, naturally occurring suppressor T cell has a phenotype similar to that of other T suppressor cells in humans, adding validity to the concept of functionally distinct T cell compartments in human blood.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190906

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  1 in total

1.  Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen).

Authors:  T Hara; S M Fu; J A Hansen
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.